Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell (Q38864365)

7 September 2017

title

Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell (English)

1 reference

7 September 2017

Jing Xiao

1 reference

7 September 2017

Weijun Chen

1 reference

7 September 2017

Yijun Lu

1 reference

7 September 2017

Xiaoli Zhang

1 reference

7 September 2017

Chensheng Fu

1 reference

7 September 2017

Zhenwen Yan

1 reference

7 September 2017

Zhenxing Zhang

1 reference

7 September 2017

Zhibin Ye

1 reference

7 September 2017

publication date

14 June 2015

1 reference

7 September 2017

published in

Inflammation Research

1 reference

7 September 2017

1 reference

7 September 2017

1 reference

7 September 2017

page(s)

603-614

1 reference

Immune system dysregulation in uremia: role of oxidative stress

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Disturbances of acquired immunity in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Aspects of immune dysfunction in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

NF-kappaB signalling in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Aldosterone stimulates nuclear factor-kappa B activity and transcription of intercellular adhesion molecule-1 and connective tissue growth factor in rat mesangial cells via serum- and glucocorticoid-inducible protein kinase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Renoprotective effects of mineralocorticoid receptor blockers in patients with proteinuric kidney diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Eplerenone inhibits aldosterone-induced renal expression of cyclooxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Mineralocorticoid receptor antagonist for renal protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Aldosterone antagonists in monotherapy are protective against streptozotocin-induced diabetic nephropathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Effect of eplerenone, a selective aldosterone blocker, on the development of diabetic nephropathy in type 2 diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Effects of PPARγ agonists against vascular and renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Synthesis of TNF-alpha by mesangial cells cultured with polymeric anionic IgA--role of MAPK and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Immunoregulatory role of TNFalpha in inflammatory kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Rapid mineralocorticoid receptor trafficking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Aldosterone and the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Cross-talk between mineralocorticoid receptor/angiotensin II type 1 receptor and mitogen-activated protein kinase pathways underlies aldosterone-induced atrial fibrotic responses in HL-1 cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Aldosterone rapidly activates protein kinase D via a mineralocorticoid receptor/EGFR trans-activation pathway in the M1 kidney CCD cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Vascular proinflammatory responses by aldosterone are mediated via c-Src trafficking to cholesterol-rich microdomains: role of PDGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Aldosterone inhibits endothelial morphogenesis and angiogenesis through the downregulation of vascular endothelial growth factor receptor-2 expression subsequent to peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

PPARγ as a therapeutic target in diabetic nephropathy and other renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Hypoxia reduces the expression and anti-inflammatory effects of peroxisome proliferator-activated receptor-gamma in human proximal renal tubular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Opposite action of peroxisome proliferator-activated receptor-gamma in regulating renal inflammation: functional switch by its ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Combination therapy with telmisartan and spironolactone alleviates L-NAME exacerbated nephrosclerosis with an increase in PPAR-gamma and decrease in TGF-beta(1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Peroxisome proliferator-activated receptor-{gamma} suppresses CYP11B2 expression and aldosterone production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

A PPARgamma agonist inhibits aldosterone-induced mesangial cell proliferation by blocking ROS-dependent EGFR intracellular signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Integrin-linked kinase plays a key role in the regulation of angiotensin II-induced renal inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0838-5

Effect of eplerenone on hypertension-associated renal damage in rats: potential role of peroxisome proliferator activated receptor gamma (PPAR-γ)

21 January 2018

1 reference

12 December 2020

The selective mineralocorticoid receptor antagonist eplerenone is protective in mild anti-GBM glomeru-lonephritis

1 reference

12 December 2020

Tumor necrosis factor alpha -238 G/A and -308 G/A polymorphisms and soluble TNF-α levels in chronic kidney disease: correlation with clinical variables

1 reference

12 December 2020

Activation of podocytes by mesangial-derived TNF-alpha: glomerulo-podocytic communication in IgA nephropathy

1 reference

12 December 2020

Neutralization of tumor necrosis factor-alpha reduces renal fibrosis and hypertension in rats with renal failure

1 reference

12 December 2020

10.1007/S00011-015-0838-5

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1030138794

0 references

1 reference